Melanóma: vizsgálatok itt: Norvégia
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Lørenskog, Oslo
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 2. fázisTaking peopleAnti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
- Where
- Oslo
- Életkor
- 18 év to 120 év
- People
- 218 worldwide
- Run by
- Melanoma Institute Australia
See details and how to joinNCT03340129 · EU 2024-518545-13-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Bodo, Drammen, Oslo
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 3. fázisTaking peopleAdjuvant Tebentafusp in High Risk Ocular Melanoma
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00 - 3. fázisTaking peopleA Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared to Ipilimumab and Nivolumab Only in Patients with Uveal Melanoma Liver Metastases – the SCANDIUM III trial.
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Vaestra Goetalandsregionen
See details and how to join2023-508156-20-00 · EU 2023-508156-20-00 - 3. fázisTaking peopleAssessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
- Where
- Aalesund, Bergen, Drammen, Kristiansand S, Lorenskog, Oslo, Stavanger, Toensberg, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 1792 worldwide
- Run by
- Uppsala University
See details and how to joinNCT06488482 · EU 2023-509994-22-00 - 3. fázisTaking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314 - 2. fázisTaking peopleNeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 27
- Run by
- Oslo University Hospital
See details and how to joinNCT06651151 · EU 2023-508649-42-00